+Follow
琪琪小不点
No personal profile
49
Follow
23
Followers
0
Topic
0
Badge
Posts
Hot
琪琪小不点
2021-03-15
$Zomedica Pharmaceuticals Corp.(ZOM)$
???
琪琪小不点
2021-03-08
$Zomedica Pharmaceuticals Corp.(ZOM)$
???
琪琪小不点
2021-03-03
???
美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%
琪琪小不点
2021-02-05
???
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3566178813813075","uuid":"3566178813813075","gmtCreate":1603089103749,"gmtModify":1611910048661,"name":"琪琪小不点","pinyin":"qqxbdqiqixiaobudian","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":23,"headSize":49,"tweetSize":177,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":38,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.25%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.68%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":322204758,"gmtCreate":1615807374874,"gmtModify":1704786792891,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322204758","isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":329805366,"gmtCreate":1615218140155,"gmtModify":1704779778414,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/329805366","isVote":1,"tweetType":1,"viewCount":261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365429140,"gmtCreate":1614772694980,"gmtModify":1704775019718,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365429140","repostId":"2116549921","repostType":2,"repost":{"id":"2116549921","pubTimestamp":1614771676,"share":"https://ttm.financial/m/news/2116549921?lang=&edition=fundamental","pubTime":"2021-03-03 19:41","market":"us","language":"zh","title":"美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2116549921","media":"智通财经网","summary":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","content":"<html><body><article><p>智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。</p></article></body></html>","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股异动 | Ocugen(OCGN.US)盘前涨逾40%，与Bharat Biotech共同开发的新冠疫苗中期有效性为81%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-03 19:41 北京时间 <a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/e559c5a8390713a5a8d4b07a2667368d","relate_stocks":{"OCGN":"Ocugen"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103031947097c066e42&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2116549921","content_text":"智通财经APP获悉，3月3日(周三)美股盘前，Ocugen(OCGN.US)股价飙升，截至北京时间19:40，该股涨42.68%，报13.64美元。此前，公司宣布与印度生物技术公司Bharat Biotech共同开发的新冠病毒疫苗中期有效性为81%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380883531,"gmtCreate":1612532597623,"gmtModify":1704872472829,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/380883531","repostId":"1170935467","repostType":4,"isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":329805366,"gmtCreate":1615218140155,"gmtModify":1704779778414,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/329805366","isVote":1,"tweetType":1,"viewCount":261,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":380883531,"gmtCreate":1612532597623,"gmtModify":1704872472829,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/380883531","repostId":"1170935467","repostType":4,"repost":{"id":"1170935467","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1612532073,"share":"https://ttm.financial/m/news/1170935467?lang=&edition=fundamental","pubTime":"2021-02-05 21:34","market":"us","language":"zh","title":"美国1月非农就业新增4.9万人，失业率创近一年新低","url":"https://stock-news.laohu8.com/highlight/detail?id=1170935467","media":"老虎资讯综合","summary":"美国1月季调后新增非农就业人口（万人）：4.9 ，预期：5，前值：-14。美国1月失业率：6.3% ，为去年3月以来新低。预期：6.7%，前值：6.7%。美国12月贸易帐（亿美元）：-666 ，预期：","content":"<p>美国1月季调后新增非农就业人口（万人）：<b>4.9</b> ，预期：5，前值：-14。</p><p>美国1月失业率：<b>6.3%</b> ，为去年3月以来新低。预期：6.7%，前值：6.7%。</p><p>美国12月贸易帐（亿美元）：<b>-666</b> ，预期：-657，前值：-681。</p><p>美国劳工部：1月，专业和商业服务以及公共和私人教育领域就业岗位的显著增加被休闲和招待、零售贸易、保健、运输和仓储领域的就业岗位减少所抵消。</p><p>分析师Chris Anstey：市场对今天非农数据预测的范围非常大，从减少25万个工作岗位到增加40万个工作岗位，这显示出，在存在如此多因素的影响下，评估经济状况有多么困难。最终公布值显示新增就业人数4.9万，这低于多数的预期值。</p><p>分析师JOSEPH：尽管非农数据令人失望，但迄今为止，市场基本上保持了数据公布之前的头寸。但随着美国经济增长，欧盟、日本和加拿大就业停滞或就业岗位减少，美元将受益于非农报告。</p><p>CNBC评美国1月非农数据：就业形势仍然具有挑战性，公司在2020年3月和4月为抗击疫情而进行裁员后，仍有数百万人失业。失业人群的一半以上已经回归工作岗位，但大多数部门的就业人数仍低于疫情前的水平，酒店行业的就业情况受损尤为严重。尽管接下来的几个月可能仍然充满挑战，但新冠疫苗为美国经济在下半年全速运转提供了希望。美国GDP在2020年下降了3.5%，第一季度特别是2021年的前景仍然不确定。尽管大多数经济数据都超出了预期，但人们仍然担心，疫情的持续存在可能会妨碍年初经济活动的正常运行。</p><p>数据公布后，美国国债利率下跌，美股三大指数期货波动不大，均维持上涨走势。</p><p><img src=\"https://static.tigerbbs.com/2cb591ab9d223f2344e12216bf2c8d1c\" tg-width=\"685\" tg-height=\"250\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国1月非农就业新增4.9万人，失业率创近一年新低</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国1月非农就业新增4.9万人，失业率创近一年新低\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-02-05 21:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>美国1月季调后新增非农就业人口（万人）：<b>4.9</b> ，预期：5，前值：-14。</p><p>美国1月失业率：<b>6.3%</b> ，为去年3月以来新低。预期：6.7%，前值：6.7%。</p><p>美国12月贸易帐（亿美元）：<b>-666</b> ，预期：-657，前值：-681。</p><p>美国劳工部：1月，专业和商业服务以及公共和私人教育领域就业岗位的显著增加被休闲和招待、零售贸易、保健、运输和仓储领域的就业岗位减少所抵消。</p><p>分析师Chris Anstey：市场对今天非农数据预测的范围非常大，从减少25万个工作岗位到增加40万个工作岗位，这显示出，在存在如此多因素的影响下，评估经济状况有多么困难。最终公布值显示新增就业人数4.9万，这低于多数的预期值。</p><p>分析师JOSEPH：尽管非农数据令人失望，但迄今为止，市场基本上保持了数据公布之前的头寸。但随着美国经济增长，欧盟、日本和加拿大就业停滞或就业岗位减少，美元将受益于非农报告。</p><p>CNBC评美国1月非农数据：就业形势仍然具有挑战性，公司在2020年3月和4月为抗击疫情而进行裁员后，仍有数百万人失业。失业人群的一半以上已经回归工作岗位，但大多数部门的就业人数仍低于疫情前的水平，酒店行业的就业情况受损尤为严重。尽管接下来的几个月可能仍然充满挑战，但新冠疫苗为美国经济在下半年全速运转提供了希望。美国GDP在2020年下降了3.5%，第一季度特别是2021年的前景仍然不确定。尽管大多数经济数据都超出了预期，但人们仍然担心，疫情的持续存在可能会妨碍年初经济活动的正常运行。</p><p>数据公布后，美国国债利率下跌，美股三大指数期货波动不大，均维持上涨走势。</p><p><img src=\"https://static.tigerbbs.com/2cb591ab9d223f2344e12216bf2c8d1c\" tg-width=\"685\" tg-height=\"250\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/f866f5d880ac7442ed06621cdcccdbfd","relate_stocks":{".DJI":"道琼斯"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170935467","content_text":"美国1月季调后新增非农就业人口（万人）：4.9 ，预期：5，前值：-14。美国1月失业率：6.3% ，为去年3月以来新低。预期：6.7%，前值：6.7%。美国12月贸易帐（亿美元）：-666 ，预期：-657，前值：-681。美国劳工部：1月，专业和商业服务以及公共和私人教育领域就业岗位的显著增加被休闲和招待、零售贸易、保健、运输和仓储领域的就业岗位减少所抵消。分析师Chris Anstey：市场对今天非农数据预测的范围非常大，从减少25万个工作岗位到增加40万个工作岗位，这显示出，在存在如此多因素的影响下，评估经济状况有多么困难。最终公布值显示新增就业人数4.9万，这低于多数的预期值。分析师JOSEPH：尽管非农数据令人失望，但迄今为止，市场基本上保持了数据公布之前的头寸。但随着美国经济增长，欧盟、日本和加拿大就业停滞或就业岗位减少，美元将受益于非农报告。CNBC评美国1月非农数据：就业形势仍然具有挑战性，公司在2020年3月和4月为抗击疫情而进行裁员后，仍有数百万人失业。失业人群的一半以上已经回归工作岗位，但大多数部门的就业人数仍低于疫情前的水平，酒店行业的就业情况受损尤为严重。尽管接下来的几个月可能仍然充满挑战，但新冠疫苗为美国经济在下半年全速运转提供了希望。美国GDP在2020年下降了3.5%，第一季度特别是2021年的前景仍然不确定。尽管大多数经济数据都超出了预期，但人们仍然担心，疫情的持续存在可能会妨碍年初经济活动的正常运行。数据公布后，美国国债利率下跌，美股三大指数期货波动不大，均维持上涨走势。","news_type":1},"isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322204758,"gmtCreate":1615807374874,"gmtModify":1704786792891,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","listText":"<a href=\"https://laohu8.com/S/ZOM\">$Zomedica Pharmaceuticals Corp.(ZOM)$</a>???","text":"$Zomedica Pharmaceuticals Corp.(ZOM)$???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322204758","isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":365429140,"gmtCreate":1614772694980,"gmtModify":1704775019718,"author":{"id":"3566178813813075","authorId":"3566178813813075","name":"琪琪小不点","avatar":"https://static.tigerbbs.com/802429dbe105c6f967ebdfbdc5209819","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3566178813813075","authorIdStr":"3566178813813075"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/365429140","repostId":"2116549921","repostType":2,"isVote":1,"tweetType":1,"viewCount":150,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
